Redhill Biopharma
RDHL
$0.46
Share price
-2.87%
Change (1 day)
-77.88%
Change (1 year)
Categories
Redhill Biopharma (RDHL) Fails to deliver data
Key failure to deliver metrics for Redhill Biopharma:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0.1 M
- Last 3 months FTD volume: $0.32 M
- Last year FTD volume: $13.79 M
Failures to deliver for Redhill Biopharma (RDHL) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Redhill Biopharma (RDHL) - since 2023
Volume in USD (price x number of shares), data since 2023Redhill Biopharma (RDHL) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.5 M | -96.31% |
| 2023 | $13.78 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Sanofi SNY | $21.22 M | $52.23 M | 🇫🇷 France |
 Merck MRK | $6.57 M | $0.15 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $18.31 M | $24.09 M | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $5.61 M | $30.31 M | 🇮🇱 Israel |
 Taro Pharmaceutical TARO | $0.14 M | $1.6 M | 🇮🇱 Israel |